Precision Medicine’s Reimbursement and Evidence Bottleneck: What AACR 2026 Liquid Biopsy Momentum Still Can’t Fix
Liquid biopsy, MRD, and AI diagnostics are accelerating. The bottleneck is coverage evidence: what signal is actionable, and who pays when it changes treatment.